Subtherapeutic serum infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab discontinuation in paediatric Crohn's disease patients

被引：0
|
作者：
Kang, B. [1 ]
Lee, K. [1 ]
Kim, K. [2 ]
Lee, J. H. [3 ]
Choe, Y. H. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul, South Korea
[2] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea
[3] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Pediat, Cheongju, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP031
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [1] Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated With Combined Immunosuppressive Therapy
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Kim, Min-Ji
    Kim, Kyunga
    Lee, Ji-Hyuk
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 644 - 652
  • [2] Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Lee, Soo-Youn
    Baek, Sun-Young
    Sohn, Insuk
    Choe, Byung-Ho
    Lee, Hae Jeong
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (02): : 189 - 197
  • [3] High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease
    Van Moerkercke, Wouter
    Ackaert, Chloe
    Compernolle, Griet
    Jurgens, Matthias
    Cleynen, Isabelle
    Van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2010, 138 (05) : S60 - S60
  • [4] Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease
    Papamichail, Konstantinos
    Casteele, Niels Vande
    Hauenstein, Scott
    Princen, Fred
    Singh, Sharat
    Ferrante, Marc
    van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2014, 146 (05) : S457 - S457
  • [5] TROUGH LEVELS OF INFLIXIMAB BETTER CORRELATE WITH COMBINED MUCOSAL AND TRANSMURAL HEALING THAN CLINICAL REMISSION IN KOREAN PATIENTS WITH CROHN'S DISEASE ON INFLIXIMAB MAINTENANCE THERAPY
    Oh, Eun Hye
    Yoon, A-Ran
    Park, Seong Ho
    Kim, Jeongseok
    Ham, Namseok
    Song, Eun Mi
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    GASTROENTEROLOGY, 2019, 156 (06) : S1138 - S1139
  • [6] Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapy
    Oh, E. H.
    Yoon, A. -R.
    Park, S. H.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S484 - S485
  • [7] Do infliximab trough levels differ between adult and paediatric patients with Crohn's disease in clinical remission?
    Cavazza, A.
    Mavroeidi, N.
    Steel, A.
    Greathead, L.
    Kelleher, W.
    Wahed, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S340 - S340
  • [8] Maintenance therapy with infliximab for paediatric Crohn's disease: impact on clinical remission and mucosal healing in Polish paediatric patients with severe Crohn's disease
    Kierkus, Jaroslaw
    Dadalski, Maciej
    Szymanska, Sylwia
    Szymanska, Edyta
    Wegner, Agnieszka
    Gorczewska, Monika
    Oracz, Grzegorz
    Woynarowski, Marek
    Ryzko, Jozef
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 26 - 30
  • [9] Serum infliximab levels and early mucosal healing in Crohn's disease
    Tang, J.
    Gao, X.
    Zhi, M.
    Zhou, H.
    Chen, H.
    Zhang, M.
    Yang, Q.
    Liang, Z.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S209 - S210
  • [10] Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Bouzkova, Eva
    Hrdlicka, Ludek
    Komarek, Arnost
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : 736 - 743
12345